Lipid-lowering effects of ethyl 2-phenacyl-3-aryl-1H-pyrrole-4-carboxylates in rodents

Molecules

Volumn 9, Issue 3, 2004, Pages 135-157

  Holub, Justin M ^a   O'Toole Colin, Kathy ^a   Getzel, Adam ^a   Argenti, Anthony ^a   Evans, Michael A ^a   Smith, Daniel C ^a   Dalglish, Gerard A ^a   Rifat, Shahzad ^a   Wilson, Donna L ^a   Taylor, Brett M ^a   Miott, Ulander ^a   Glersaye, Josephine ^a   Lam, Kam Suet ^a   McCranor, Bryan J ^a   Berkowitz, Joshua D ^a   Miller, Robert B ^b   Lukens, John R ^b   Krumpe, Keith ^c   Gupton, John T ^b   Burnham, Bruce S ^a  

^a RIDER UNIVERSITY   (United States)

^b UNIVERSITY OF RICHMOND   (United States)

^c UNIVERSITY OF NORTH CAROLINA AT ASHEVILLE   (United States)

Author keywords

Cholesterol; Hypolipidemia; Pyrrole; Triglyceride

Indexed keywords

ATORVASTATIN; CHOLESTEROL; FLUINDOSTATIN; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; PYRROLE DERIVATIVE; TRIACYLGLYCEROL; ACETOPHENONE DERIVATIVE; ANTILIPEMIC AGENT; CARBOXYLIC ACID; HEPTANOIC ACID DERIVATIVE; INDOLE DERIVATIVE; LOW DENSITY LIPOPROTEIN; MONOUNSATURATED FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SYNTHESIS; HYPOLIPEMIA; LIVER CELL; MALE; MOUSE; NONHUMAN; POLYMERIZATION; RAT; SUBSTITUTION REACTION; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; CHEMISTRY; SPRAGUE DAWLEY RAT; SYNTHESIS;

ACETOPHENONES; ANIMALS; ANTILIPEMIC AGENTS; CARBOXYLIC ACIDS; CHOLESTEROL, HDL; FATTY ACIDS, MONOUNSATURATED; HEPTANOIC ACIDS; INDOLES; LIPOPROTEINS, LDL; MALE; MICE; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 3242788730     PISSN: 14203049     EISSN: None     Source Type: Journal    
DOI: 10.3390/90300134     Document Type: Article

References (37)

1. Evans, M.A.; Smith, D.C.; Holub, J.M.; Argenti, A.; Hoff, M.; Dalglish, G.A.; Wilson, D.L.; Taylor, B.M.; Berkowitz, J.D.; Burnham, B.S.; Krumpe, K.; Gupton, J.T.; Scarlett, T.C.; Durham, R.; Hall, I.H. "Synthesis and Cytotoxicity of Substituted Ethyl 2-phenacyl-3-phenylpyrrole-4-carboxylates. " Arch. Pharm. Pharm. Med. Chem. 2003, 336, 181-190.
2. Burnham, B.S.; Gupton, J.T.; Krumpe, K.E.; Webb, T.; Shuford, J.; Bowers, B.; Warren, A.E.; Barnes, C.; Hall, I.H. "Cytotoxicity of Substituted Alkyl-3,4-bis(4-methoxyphenyl)pyrrole-2-carboxylates in L1210 Lymphoid Leukemia Cells." Arch. Pharm. Pharm. Med. Chem. 1998, 331, 337-341.
3. 4 Leukemia Cells." Pharmazie 1999, 54, 691-697.
4. Gupton, J.T.; Burnham, B.S.; Krumpe, K.E.; Du, K.; Sikorski, J.A.; Warren, A.E.; Barnes, C.; Hall, I.H. "Synthesis and Cytotoxicity of 2,4-Disubstituted and 2,3,4-Trisubstituted Brominated Pyrroles in Murine and Human Cultured Tumor Cells." Arch. Pharm. Pharm. Med. Chem.. 2000, 333, 3-9.
5. Procopiou, P.A.; Draper, C.D.; Hutson, J.L.; Inglis, G.G.; Ross, B.C.; Watson, N.S. "Inhibitors of cholesterol biosynthesis. 2. 3,5-Dihydroxy-7-(N-pyrrolyl)-6-heptenoates, a novel series of HMG-CoA reductase inhibitors." J. Med. Chem. 1993, 36, 3658-3662.
6. Roth, B.D.; Blankley, C.J.; Chucholowski, A.W.; Ferguson, E.; Hoefle, M.L.; Ortwine, D.F.; Newton, R.S.; Sekerke, C.S.; Sliskovic, D.R.; Stratton, C.D.; Wilson, M.W. "Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran-2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus." J. Med. Chem. 1991, 34, 357-366.
7. Jendralla, H.; Baader, E.; Bartmann, W.; Beck, G.; Bergmann, A.; Granzer, E.; von Kerekjarto, B.; Kesseler, K.; Krause, R.; Schubert, W.; Wess, G. "Synthesis and biological activity of new HMG-CoA reductase inhibitors. 2. Derivatives of 7-(1H-pyrrol-3-yl)-substituted-3,5-dihydroxy-hept-6(E)-enoic (-heptanoic) acids." J. Med. Chem. 1990, 33, 61-70.
8. Roth BD, Ortwine DF, Hoefle ML, Stratton CD, Sliskovic DR, Wilson MW, Newton RS. "Inhibitors of cholesterol biosynthesis. 1. trans-6-(2-pyrrol-1- ylethyl)-4-hydroxypyran-2-ones, a novel series of HMG-CoA reductase inhibitors. 1. Effects of structural modifications at the 2- and 5-positions of the pyrrole nucleus." J. Med. Chem. 1990, 33, 21-31.
9. Bocan, T.M.; Ferguson, E.; McNally, W.; Uhlendorf, P.D.; Bak Mueller, S.; Dehart, P.; Sliskovic, D.R.; Roth, B.D.; Krause, B.R.; Newton, R.S.; "Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: comparison with selected HMG-CoA reductase inhibitors." Biochim. Biophys Acta 1992, 1123, 133-144.
10. Watanabe, M.; Koike, H.; Ishiba, T.; Okada, T.; Seo, S.; Hirai, K. "Synthesis and biological activity of methanesulfonamide pyrimidine- and N-methanesulfonyl pyrrole-substituted 3,5-dihydroxy-6-heptenoates, a novel series of HMG-CoA reductase inhibitors." Bioorg. Med. Chem. 1997, 5, 437-444.
11. Corsini, A.; Bellosta, S.; Baetta, R.; Fumagalli, R.; Paoletti, R.; Bernini, F. "New insights into the pharmacodynamic and pharmacokinetic properties of statins." Pharmcol. Ther. 1999, 84, 413-428.
12. th Ed., Koda-Kimble, M.A.; Young, L.Y., editors; Lippincott Williams and Wilkins: Philadelphia, PA, 2001; pp. 11-1 to 11-43.
13. Takemoto, M.; Liao, J.K. "Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors." Arterioscler. Thromb. Vasc. Biol. 2001, 21, 1712-1719.
14. Shovman, O.; Levy, Y.; Gilburd, B.; Shoenfeld, Y. "Antiinflammatory and immunomodulatory properties of statins." Immunol. Res. 2002, 25, 271-285.
15. Lefer, D.J. "Statins as potent antiinflammatory drugs." Circulation 2002, 106, 2041-2042.
16. Leung, B.P.; Sattar, N.; Crilly, A.; Prach, M.; McCarey, D.W.; Payne, H.; Madhok, R.; Campbell, C.; Gracie, J.A.; Liew, F.Y.; McInnes, I.B. "A novel anti-inflammatory role for simvastatin in inflammatory arthritis." J. Immunol. 2003, 170, 1524-1530.
17. Vega, G.L.; Weiner, M.F.; Lipton, A.M.; Von Bergmann, K.; Lutjohann, D.; Moore, C.; Svetlik, D. "Reduction in Levels of 24S-Hydroxycholesterol by Statin Treatment in Patients with Alzheimer Disease." Arch. Neurol. 2003, 60, 510-515.
18. Crisby, M.; Carlson, L.A.; Winblad, B. "Statins in the Prevention and Treatment of Alzheimer's Disease." Alzheimer Dis. Assoc. Disord. 2002, 16, 131-136.
19. Austen, B.; Christodoulou G.; Terry, J.E. "Relationship Between Cholesterol Levels, Statins and Alzheimer's Disease in the Human Population." J. Nutr. Health Aging 2002, 6, 377-382.
20. Wolozin, B.; Kellman, W., Rousseau, P.; Celesia, G.G., Siegel, G. "Decreased Prevalence of Alzheimer Disease Associated with 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitors." Arch Neurol. 2000, 57, 1439-1443.
21. Kaneko I.; Hazama-Shimda y, Endo A. "Inhibitory effects on lipid metabolism in cultured cells of ML-236B, a potent inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase." Eur J. Biochem, 1978, 87, 313-321.
22. Burnham, B.S.; Sood, A.; Tomasz, J.; Powell, W.J.; Spielvogel, B.F.; Chen, S.Y.; Hall, I.H. "The Hypolipidemic Activity of Boronated Nucleosides in Male Mice and Rats." Metal-Based Drugs 1996, 3, 173-183.
23. Hall, I.H.; Burnham, B.S.; Elkins, A.; Sood, A.; Powell, W.; Tomasz, J.; Spielvogel, B.F. "Boronated Pyrimidines and Purines as Cytotoxic, Hypolipidemic and Anti-inflammatory Agents." Metal-Based Drugs 1996, 3, 155-160.
24. Burnham, B.S.; Chen, S.Y.; Sood, A.; Spielvogel, B.F.; Hall, I.H. "Synthesis and Cytotoxicity of Amine-Borane Adducts of Cyclohexylamines and Toluidines." Pharmazie 1995, 50, 779-783.
25. Burnham, B.S.; Chen, S.Y.; Sood, A.; Spielvogel, B.F.; Hall, I.H. "Hypolipidemic Activity of Amine-Borane Adducts of Cyclohexylamine and Toluidine in Rodents." Metal-Based Drugs 1995, 2, 221-232.
26. Hall, I.H.; Burnham, B.S; Rajendran, K.G.; Chen, S.Y.; Sood, A.; Spielvogel B.F. .; Shaw, B.R. "Hypolipidemic Activity of Boronated Nucleosides and Nucleotides in Rodents," Biomed Pharmacother. 1993, 47, 79-87.
27. Sood, A.; Spielvogel, B.F.; Shaw, B.R.; Carlton, L.; Burnham, B.S.; Hall, E.; Hall, I.H. "The Synthesis and Antineoplastic Activity of 2′-Deoxynucleoside-cyanoboranes in Murine and Human Cultured Cells," Anti-Cancer Research 1992, 12, 335-344.
28. Sood, C.; Sood, A.; Spielvogel, B.F.; Yousef, J.; Burnham, B.; Hall, I. "Synthesis and Antineoplastic Activity of Some Cyano-, Carboxy-, Carbomethoxy-, and Carbamoylborane Adducts of Heterocyclic Amines," J Pharm. Sci. 1991, 80, 1133-1140.
29. Hall, I.H.; Hall, E.S.; Wong, O.T. "The antineoplastic activity of 2,3-dihydrophthalazine-1,4-dione and N-butyl-2,3-dihydrophthalazine-I,4-dione in human and murine tumor cells." Anti-Cancer Drugs, 1992, 3, 55-
30. Hall, I.H.; Lee, K.H.; Starnes, C.O.; Muraoka, O.; Sumida, Y.; Waddell, T.G. "Antihyperlipidemic activity of sesquiterpene lactones and related compounds." J. Pharm. Sci. 1980, 69, 694-
31. Simlot, R.; Izydore, R.A.; Wong, O.T.; Hall, I.H. "Synthesis and hypolipidemic activity of 4-substituted 1-acyl-1,2,4-triazolidine-3,5-dione in rodents." J. Pharmacol Sci. 1993, 82, 408-415.
32. Gupton, J.T.; Krumpe, K.E.; Burnham, B.S.; Webb, T.; Shuford, R.J.; Sikorski, J. "The Application of Vinylogous Imminium Salt Derivatives to a Regiocontrolled and Efficient Relay Synthesis of Lukianol A and Related Marine Natural Products." Tetrahedron 1999, 55, 14515-14522.
33. Gupton, J.T.; Krumpe, K.E.; Burnham, B.S.; Dwornik, K.A.; Petrich, S.A.; Du, X.K.; Bruce, M.A.; Vu, P.; Vargas, M.; Keertikar, K.M.; Hosein, K.N.; Jones, C.R.; Sikorski, J.A. "The Application of Disubstituted Vinylogous Iminium Salts and Related Synthons to the Regiocontrolled Preparation of Unsymmetrical 2,3,4-Trisubstituted Pyrroles." Tetrahedron 1998, 45, 5075-5088.
34. Gordon, A.J.; Ford, R.A. The Chemist's Companion: A Handbook of Practical Data, Techniques, and References; John Wiley and Sons: New York, 1972; pp. 429-436.
35. Gupton, J.T.; Krolikowski, D.A.; Yu, R.H.; Sikorski, J.A.; Riesinger, S.W. "Application of 2-substituted vinamidinium salts to the synthesis of 2,4-disubstituted pyrroles." J. Org. Chem 1990, 55, 4735-4740.
36. Gupton, J.T.; Clough, S.C.; Miller, R.B.; Lukens, J.R.; Henry, C.A.; Kanters R.P.F.; James A. Sikorski, J.A. "The application of vinylogous iminium salt derivatives to the synthesis of Ningalin B hexamethyl ether." Tetrahedron, 2003, 59, 207-215
37. Bligh, E.G.; Dyer, W.J. "A rapid method of total lipid extraction and purification." Can. J. Biochem. Physiol. 1959, 37, 911-917.